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Results
Identification of a SNP in the distal enhancer of PU.1 that is more frequent 







































Genomic analysis of distal URE of PU.1. (A) Schematics of 
genomic locus of human PU.1 gene including its 5 exons 
(white box) and –16-kb URE consisting of 2 highly con-
served homology regions (gray boxes). Localization of the 
probes for fluorescence in situ hybridization (RP11-17G12 
and RP11-379M04) is indicated by lines with filled circles at 
the ends. The long (q) and short (p) arms of chromosome 
11 and the band 11.2 are indicated. (B) Fluorescence in 
situ hybridization with probe RP11-379M04 covering the 
URE locus. Left: Metaphase FISH showing 2 signals on 
each chromosome 11 (arrows). Right: Interphase FISH 
of 1 representative of 80 patients with 2 signals per cell. 
(C) Direct sequencing identifies SNP in the first homology 
region of PU.1 URE. Representative sequencing traces 
of patients with wild-type site (WT hom), heterozygous 
site (het), and homozygous SNP (SNP hom) shown. (D) 
Identification of a SNP in the second homology region of 
URE. Representative sequencing graphs of patients with 
wild-type site, heterozygous site, and homozygous SNP 
shown. (E) Higher abundance of the homozygous SNP 
in first homology region in patients with AML with com-
plex karyotypes. Bar diagram shows SNP status of nor-
mal controls and AML with normal karyotype, with aber-
rant noncomplex karyotype, and with complex karyotype. 
*P = 0.027 (χ2) and P = 0.018 (Fisher’s exact); odds ratio, 
2.9; odds ratio 95% confidence interval, 1.22–6.83. (F) 
Frequency of SNP in the second homology region of URE 
is not different between normal controls or AML.
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Binding of SATB1 to the URE is disrupted by the SNP. We next sought 
to identify potential binding factors at this site that may medi-








plays an  important  role  in chromatin 


































Frequency of the SNP in the first and second homology regions of the URE of PU.1  
in patients with AML and in healthy control subjects
Parameter	 Homozygous	 Heterozygous		 Homozygous		 Total	
	 WT	 SNP/WT	 SNP	
SNP,	first	homology	region,	no.	(%)
Healthy control 54 (34.2) 75 (47.5) 29 (18.4) 158 (100)
AML, total 71 (34.0) 105 (50.2) 33 (15.8) 209 (100)
AML, normal karyotype 30 (33.3) 51 (56.7) 9 (10.0) 90 (100)
AML, aberrant noncomplex karyotype 15 (30.6) 27 (55.2) 7 (14.3) 49 (100)
AML, complex karyotype 26 (37.1) 27 (38.6) 17 (24.3)A 70 (100)
SNP,	second	homology	region,	no.	(%)
Healthy control 43 (81.1) 6 (11.3) 4 (7.5) 53 (100)
AML, total 85 (77.3) 20 (18.2) 5 (4.5) 110 (100)
AML, normal karyotype 33 (70.2) 12 (25.5) 2 (4.3) 47 (100)
AML, aberrant noncomplex karyotype 25 (78.1) 5 (15.6) 2 (6.3) 32 (100)
AML, complex karyotype 27 (87.1) 3 (9.7) 1 (3.2) 31 (100)
Different cytogenetic subgroups are indicated. Absolute numbers are shown. AP = 0.027 (χ2) and  
P = 0.018 (Fisher’s exact); odds ratio, 2.9; odds ratio 95% confidence interval, 1.22–6.83.
Figure 2
The SNP in the first homology region of the URE of PU.1 leads to 
reduced enhancer activity. (A) Schematics of the reporter constructs 
utilized for stable transfections of U937 myeloid cells. Top: The proxi-
mal promoter of PU.1 in the pXP2 luciferase vector. Middle: The wild-
type URE plus the proximal promoter of PU.1. Bottom: The SNP URE 
plus the proximal promoter of PU.1. The point mutation representing 
the SNP is indicated by a star. (B and C) Luciferase reporter assays 
after stable transfection of the above-described constructs into U937 
cells shows reduced enhancer activity of the point-mutated URE. (B) 
The mean luciferase activity of 3 independent clones is displayed. 
Error bars indicate SD. (C) The mean luciferase activity of 3 inde-
pendent cell pools is shown. Luciferase activity was normalized to 
transgene copy number as determined by Southern blotting. Error 
bars indicate SD. *P < 0.001.
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The SNP in the first homology region of the URE of 
PU.1 diminishes binding of SATB1. (A) Chromatin 
immunoprecipitation shows SATB1 binding to the URE 
in U937 and HL60 cells. The genomic region of the 
putative SATB1 binding site was PCR amplified after 
reverse crosslink of the immunoprecipitates. An input 
control and precipitates utilizing a SATB1 antibody, no 
antibody, or a nonspecific control antibody are shown. 
PCR products were verified by sequencing. (B) EMSA 
utilizing nuclear extracts of U937 cells and gel-purified 
probes (WT probe, 32P, and SNP probe, 32P) covering 
the SATB1 binding site are shown. The wild-type probe 
(WT oligo) and a previously described SATB1 binding 
probe (SATB1 IgH site) were used for competition. A 
SATB1 antibody was used for supershift. A labeled Sp1 
binding probe served as a loading control in 2 lanes. 
The 32P-labeled SATB1 IgH site served as positive 
control. The presence (+) or absence (–) of the respec-
tive reagents is indicated for each lane. The probes are 
shown below the gel.
research article


















The homozygous SNP is associated with low PU.1 
expression in progenitors of patients with AML. To 
address the question of whether the SNP affects 







SATB1 is a URE-dependent positive regulator of 
PU.1 in myeloid cells. (A) SATB1-directed siRNA-
expressing construct PU.1 mRNA was significantly 
reduced upon siRNA-mediated knockdown of SATB1 
(U937 siSATB1). n = 3. (B) Western blotting shows 
diminished PU.1 protein level after siRNA-mediated 
downregulation of SATB1 protein in stably transfected 
U937 cells. β-actin protein served as control. (C) Len-
tiviral overexpression of SATB1 in U937 cells leads to 
increased PU.1 expression. We utilized IRES-GFP-
SATB1 lentivirus to transduce U937 cells. GFP+ cells 
were FACS sorted and subjected to mRNA expres-
sion analysis. Sorted GFP– cells and cells infected 
with empty IRES-GFP lentivirus served as control. 
Gene expression data normalized to GAPDH. n = 3. 
(D) SATB1 overexpression in the absence of URE 
does not lead to PU.1 upregulation. Cells derived 
from URE–/– mice were treated with SATB1-express-
ing lentivirus, GFP+ and GFP– cells FACS sorted, and 
SATB1 and PU.1 expression measured. While SATB1 
expression was significantly increased in IRES-GFP-
SATB1–infected cells (SATB1 GFP+), there was no 
upregulation of PU.1 expression in URE–/– cells. n = 3. 
(E and F) Lentiviral overexpression of SATB1 in sort-
ed Lin–Kit+ progenitors from wild-type littermates and 
URE-knockout mice. Lin–Kit+ cells were FACS sorted 
and infected with empty control virus or IRES-GFP-
SATB1 virus. GFP+ cells were sorted and subjected to 
quantitative RT-PCR. (E) Sorted wild-type progenitors. 
n = 3. (F) Sorted URE–/– progenitors. n = 3. (G) Neo-
mycin resistance SATB1 siRNA expression construct 
was stably transfected into URE–/– cells and SATB1 
and PU.1 expression levels determined. An empty 
construct served as control. Mean ± SD shown.
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SATB1- and SNP-dependent downregulation of 
PU.1 in distinct myeloid progenitor subsets in vivo. 
(A) wbc from fetal livers of SATB1-knockout mice 
were harvested and KLS cells (Lin–c-kit+Sca1+), 
CMPs (Lin–c-kit+Sca1–CD34lowFcγII/IIIRlow), GMPs 
(Lin–c-kit+Sca1–CD34+FcγII/IIIR+), and MEPs (Lin– 
c-kit+Sca1–CD34–FcγII/IIIR–) were separated by mul-
ticolor FACS sorting. PU.1 expression was deter-
mined by quantitative RT-PCR. GAPDH served 
as a control. SD is indicated by error bars (n = 3). 
While there are no significant changes in total wbc, 
KLS cells, or CMPs, PU.1 expression is markedly 
decreased in GMPs and MEPs of SATB1–/– mice 
in comparison with wild-type littermates. (B) Total 
BM of WT/WT (n = 16) and SNP/SNP (n = 5) 
patients was examined by quantitative RT-PCR. 
GAPDH expression served as a control. Averages 
and standard deviations (error bars) are shown. 
(C) Lin–CD34+CD38–Thy1low HSCs of WT/WT 
(n = 8) and SNP/SNP (n = 4) patients were sepa-
rated by multicolor FACS and PU. 1 expression 
was determined by quantitative RT-PCR. (D) Lin–
CD34+CD38+CD123+CD45RA+ GMPs of WT/WT 
(n = 7) and SNP/SNP patients (n = 3) were FACS 
sorted and PU.1 expression was measured by quan-
titative RT-PCR. Expression of GAPDH was used 
as a control. (E) Lin–CD34+CD38+CD123–CD45RA– 
MEPs of WT/WT (n = 7) and SNP/SNP patients 
(n = 3) were FACS sorted and PU.1 expression was 
measured by quantitative RT-PCR. Error bars rep-
resent standard deviation. Statistical significance is 
indicated by asterisks. P < 0.01.
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myeloid  leukemia,  inactivated  in mice by  gene 
deletion and mutation of its DNA binding domain. 
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